RE:RE:RE:RE:We need Clinical Proof On November 12th 2019 Dr.Lilge said this at a lecture in Paris:
"Through a variety of ongoing clinical trials in oncology, including Theralase's Study II, PDT has been gaining increased traction. As a leading example of combining the industry defining science and technology, Theralase is continuously improving the quality of PDT treatment with TLD-1433 and the optimized TLC-3200 laser system. The future of advanced PDT in cancer treatment will need to be robust and personalized.”
For me Dr.Lilge could not have told us that ‘Theralase is continuously improving the quality of PDT treatment with TLD-1433 and the optimized TLC-3200 laser system’ if the 30-day results for 1 & 2 in Phase 2 - which he would have received by then - had been less positive than those for 5 & 6 in Phase IB at the same stage or if a further treatment up to November the 12th was suggesting the possibility of any such inferior outcome.